E75.29
BillableOther sphingolipidosis
HCC Category Mapping
RxHCCHCC 41 — Lysosomal Storage Disorders
0.000What This Code Means
A group of rare inherited metabolic disorders involving abnormal accumulation of fatty substances in cells, causing progressive damage to the nervous system and other organs.
Coding Tips
- •Use this code only when the specific sphingolipidosis type is not identified or documented
- •Review medical record for diagnostic test results that may specify the exact lipid storage disorder
Clinical Significance
Other sphingolipidosis represents rare inherited lysosomal storage disorders where specific sphingolipids accumulate abnormally in cells, causing progressive neurological and organ damage. These conditions require lifelong management and significantly increase resource utilization due to their chronic, progressive nature and need for specialist care.
Documentation Requirements
- ✓Specific type of sphingolipidosis documented (e.g., Krabbe disease variant, metachromatic leukodystrophy variant) or statement that type is 'other' or atypical
- ✓Confirmatory diagnostic testing results (enzyme assay, genetic testing, or biopsy findings)
- ✓Current disease manifestations and affected organ systems
- ✓Treatment plan including enzyme replacement therapy, substrate reduction therapy, or supportive care
- ✓Provider assessment of disease status (stable, progressing, or in remission)
Commonly Confused Codes
E75.21 — Fabry disease: a specific sphingolipidosis with alpha-galactosidase A deficiency, has its own codeE75.22 — Gaucher disease: specific sphingolipidosis with glucocerebrosidase deficiency, coded separatelyE75.23 — Krabbe disease: specific globoid cell leukodystrophy, not classified under 'other'E75.25 — Metachromatic leukodystrophy: has its own specific code, do not use E75.29E75.3 — Sphingolipidosis, unspecified: use only when no specific type is identified at all